Monoclonal antibody recognition of members of the meningococcal P1.10 variable region family: implications for serological typing and vaccine design.

Microbiology
J SukerMartin C J Maiden

Abstract

Identification of antigenic variants of the PorA protein of Neisseria meningitidis with specific mAbs (serosubtyping) is used in meningococcal strain characterization and the resultant data has been exploited in the design of novel multivalent vaccines against this important pathogen. The reactivity of the P1.10 serosubtyping mAb MN20F4.17 with eight members of the meningococcal P1.10 variable region (VR) family (prototype P1.10 and variants P1.10a-P1.10g), identified by nucleotide sequence analysis of porA genes, was investigated. Analysis of overlapping synthetic octapeptides by ELISA demonstrated that the peptide sequence, QNQRPTL, present only in the prototype P1.10, was sufficient for binding of the mAb. A linear peptide of 14 amino acids, containing the minimum epitope, inhibited binding of mAb MN20F4.17 to whole cells in a competitive ELISA. This binding was weak compared with a tethered peptide or the native protein. In whole-cell ELISA or dot-blot assays using low concentrations of mAb MN20F4.17 only the prototype P1.10 was detected. However, when higher concentrations of antibody were used the prototype P1.10 was detected, together with variants P1.10a, P1.10c and P1.10e by whole-cell ELISA and P1.10a and P1.10c by th...Continue Reading

References

Sep 1, 1991·Infection and Immunity·P van der LeyJ T Poolman
Dec 7, 1991·Lancet·P E Fine
Sep 24, 1987·Journal of Immunological Methods·H M GeysenP G Schoofs
Apr 1, 1989·Clinical Microbiology Reviews·C E Frasch
Apr 1, 1989·Clinical Microbiology Reviews·B SchwartzC V Broome
Jul 1, 1986·The Journal of Antimicrobial Chemotherapy·C V Broome
Dec 1, 1988·FEMS Microbiology Immunology·H Abdillahi, J T Poolman
Dec 1, 1985·European Journal of Clinical Microbiology·C E Frasch
Jan 1, 1983·Reviews of Infectious Diseases·H Peltola
Jan 1, 1993·Journal of Medical Microbiology·E WedegeL O Frøholm
Jul 1, 1993·Journal of Medical Microbiology·C A Hart, T R Rogers
Feb 1, 1994·Journal of Clinical Microbiology·D A CaugantL O Frøholm

❮ Previous
Next ❯

Citations

Jul 23, 1998·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·D A Caugant
Nov 18, 2000·Infection and Immunity·A van der EndeJ Dankert
Dec 16, 2006·FEMS Microbiology Reviews·Keith A JolleyMartin C J Maiden
May 9, 2000·Clinical and Diagnostic Laboratory Immunology·J JelfsD A Caugant
Nov 5, 1998·Clinical and Diagnostic Laboratory Immunology·C T SacchiL W Mayer
Nov 30, 1999·Clinical and Diagnostic Laboratory Immunology·M C MaidenI M Feavers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.